All News

NABP announced that Patient Care Infusion dba Arizona Home Care has received accreditation through the association's durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) accreditation program.

A Government Accountability Office report found enrollment delays and excessive payments for beneficiaries who are eligible for both Medicare and Medicaid.

The National Coalition of Pharmaceutical Distributors (NCPD) has come out in support of a lawsuit aimed at preventing the implementation of new pedigree requirements for the Prescription Drug Marketing Act (PDMA).

A federal judge ruled that AstraZeneca, a subsidiary of Schering-Plough, and Bristol-Myers Squibb are guilty of reporting false average wholesale prices for a number of prescription drugs in violation of a Massachusetts consumer protection law.

The Academy of Managed Care Pharmacy and ASHP have approved a new standard for managed care pharmacy residencies that aims to improve training for pharmacists as they prepare for this specialized area of practice. T

The new labeling requirements came about after the USP reviewed numerous case reports suggesting a potential link between ingestion of products containing green tea extracts and black cohosh and liver damage.

The new service, called HybridRx, is an extension of the company's onsite healthcare solution, Hybrid Health, which offers a comprehensive range of healthcare services for client employees, retirees, and their dependents.

A Massachusetts judge ordered Wal-Mart to pay $2 million for wrongfully terminating a pharmacist. Cynthia Haddad was fired by Wal-Mart in April 2004 after asking to be paid the same as her male colleagues.

A progesterone vaginal insert has been OK'd for marketing and will be sold under the name Endometrin, from Ferring Pharmaceuticals. The new formulation will be available in a100-mg strength and is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology treatment for infertile women.

The American Academy of Pediatrics now recommends a two-dose series of the varicella vaccine for children 12 months through 12 years of age, with the doses separated by at least three months.

The FDA has given the go-ahead to Cephalon Inc. to market armodafinil (Nuvigil) for the treatment of excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome, narcolepsy, and shift-work sleep disorder.

As part of the sampling effort being done for the investigation into toothpaste made in China, the FDA has updated the list of products that have tested positive for diethylene glycol (DEG) on its Web site.

The Council for Responsible Nutrition (CRN) has launched a multiyear, multimillion-dollar public relations campaign that will focus on "whys and ways" people incorporate dietary supplements into their lifestyle.

According to Repro-Med Systems, which designs and manufactures medical devices for medical respiratory products and infusion therapy, notification received from CMS indicated that the Freedom60 has been rereviewed for Medicare billing.

Sepracor is unhappy with the way CMS proposes to pay for its Xopenex (levalbuterol HCl) Inhalation Solution. CMS plans to bundle levalbuterol with generic albuterol inhalation solutions under Medicare Part B.

The National Institute for Occupational Safety & Health (NIOSH) has proposed a new list of 62 medications that it thinks fit its criteria for hazardous drugs and a list of 88 products that don't fit those criteria.

The Department of Defense has issued a notice advising interested parties of a demonstration project in which the department will evaluate allowing selected OTCs to be included on the TRICARE uniform formulary.

Humana announced that fully insured commercial Humana health insurance plan enrollees will have their first copayment for a generic equivalent waived when utilizing the insurer's prescription home delivery service, Right Source.

NACDS called for the enactment of provisions that would provide healthcare cost savings, expand access to medications, facilitate effective communications with consumers, and foster operational efficiency for community pharmacy.

In federal court papers filed last week, NCPA stated its opposition to the proposed settlement in the average manufacturer price-fixing suit, insisting that it might radically reduce or eliminate the already-thin profit margin for community pharmacies.